Segui
Sarah van Tol
Sarah van Tol
Postdoctoral Fellow, Rocky Mountain Laboratories, NIH/NIAID)
Email verificata su nih.gov
Titolo
Citata da
Citata da
Anno
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species
M Moustaqil, E Ollivier, HP Chiu, S Van Tol, P Rudolffi-Soto, C Stevens, ...
Emerging microbes & infections 10 (1), 178-195, 2021
2352021
The TRIMendous role of TRIMs in virus–host interactions
S Van Tol, A Hage, MI Giraldo, P Bharaj, R Rajsbaum
Vaccines 5 (3), 23, 2017
1382017
Envelope protein ubiquitination drives entry and pathogenesis of Zika virus
MI Giraldo, H Xia, L Aguilera-Aguirre, A Hage, S van Tol, C Shan, X Xie, ...
Nature 585 (7825), 414-419, 2020
1322020
TRIM proteins in host defense and viral pathogenesis
MI Giraldo, A Hage, S van Tol, R Rajsbaum
Current Clinical Microbiology Reports 7, 101-114, 2020
712020
Influences of the mosquito microbiota on vector competence
S Van Tol, G Dimopoulos
Advances in insect physiology 51, 243-291, 2016
532016
The role of the host ubiquitin system in promoting replication of emergent viruses
KM Valerdi, A Hage, S van Tol, R Rajsbaum, MI Giraldo
Viruses 13 (3), 369, 2021
472021
The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity
A Hage, P Bharaj, S van Tol, MI Giraldo, M Gonzalez-Orozco, KM Valerdi, ...
Cell reports 38 (10), 2022
362022
Hydrogen cyanide produced by the soil bacterium Chromobacterium sp. Panama contributes to mortality in Anopheles gambiae mosquito larvae
SM Short, S Van Tol, HJ MacLeod, G Dimopoulos
Scientific reports 8 (1), 8358, 2018
342018
VAMP8 contributes to the TRIM6-mediated type I interferon antiviral response during West Nile virus infection
S Van Tol, C Atkins, P Bharaj, KN Johnson, A Hage, AN Freiberg, ...
Journal of virology 94 (2), 10.1128/jvi. 01454-19, 2020
322020
The mosquito adulticidal Chromobacterium sp. Panama causes transgenerational impacts on fitness parameters and elicits xenobiotic gene responses
SM Short, S Van Tol, B Smith, Y Dong, G Dimopoulos
Parasites & vectors 11, 1-15, 2018
182018
Antigenic and biological characterization of ORF2–6 variants at early times following PRRSV infection
AB Evans, H Loyd, JR Dunkelberger, S Van Tol, MJ Bolton, KS Dorman, ...
Viruses 9 (5), 113, 2017
182017
SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for …
M Moustaqil, E Ollivier, HP Chiu, S Van Tol, P Rudolffi-Soto, C Stevens, ...
Biorxiv, 2020.06. 05.135699, 2020
162020
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species …
M Moustaqil, E Ollivier, HP Chiu, S Van Tol, P Rudolffi-Soto, C Stevens, ...
152021
Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly
S van Tol, B Kalveram, PA Ilinykh, A Ronk, K Huang, L Aguilera-Aguirre, ...
PLoS pathogens 18 (5), e1010532, 2022
132022
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication
CA Rodríguez-Salazar, S van Tol, O Mailhot, M Gonzalez-Orozco, ...
PLoS biology 22 (2), e3002544, 2024
52024
A bivalent Adenovirus-Vectored Vaccine induces a robust humoral response, but does not protect cynomolgus macaques against a lethal challenge with Sudan virus
S van Tol, P Fletcher, F Feldmann, RK Mukesh, JR Port, S Gallogly, ...
The Journal of Infectious Diseases, jiae056, 2024
32024
Pteropus vampyrus TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors
S van Tol, A Hage, R Rajsbaum, AN Freiberg
Viruses 15 (11), 2147, 2023
32023
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication
M Gonzalez-Orozco, H Tseng, A Hage, H Xia, P Behera, K Afreen, ...
Nature communications 15 (1), 10438, 2024
22024
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication creating new therapeutic opportunities
CA Rodríguez-Salazar, S van Tol, O Mailhot, G Galdino, N Teruel, ...
bioRxiv, 2023
22023
Lighting the way to host-directed immunotherapeutics
S van Tol, A Hage, R Rajsbaum
Cell Chemical Biology 29 (7), 1067-1070, 2022
12022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20